William Plovanic
Stock Analyst at Canaccord Genuity
(4.18)
# 1,551
Out of 4,993 analysts
669
Total ratings
46.9%
Success rate
5.9%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Reiterated: Buy | $300 → $385 | $274.19 | +40.41% | 23 | Sep 18, 2026 | |
| TMDX TransMedics Group | Reiterated: Buy | $95 | $87.29 | +8.83% | 58 | Sep 11, 2026 | |
| IRTC iRhythm Holdings | Reiterated: Buy | $196 | $110.37 | +77.58% | 36 | Aug 27, 2026 | |
| TLSI TriSalus Life Sciences | Reiterated: Buy | $7 | $4.98 | +40.56% | 22 | Aug 26, 2026 | |
| AORT Artivion | Reiterated: Buy | $39 → $40 | $23.63 | +69.28% | 15 | Aug 18, 2026 | |
| CBLL CeriBell | Reiterated: Buy | $25 → $26 | $24.25 | +7.22% | 15 | Aug 13, 2026 | |
| ATRC AtriCure | Reiterated: Buy | $55 | $58.32 | -5.69% | 38 | Aug 11, 2026 | |
| CVRX CVRx, Inc. | Reiterated: Buy | $5 | $2.97 | +68.35% | 39 | Aug 11, 2026 | |
| PLSE Pulse Biosciences | Reiterated: Buy | $32 → $43 | $53.31 | -19.34% | 3 | Aug 11, 2026 | |
| TNDM Tandem Diabetes Care | Reiterated: Buy | $40 | $17.62 | +127.01% | 15 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $249 → $179 | $140.53 | +27.37% | 44 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $374 | $318.78 | +17.32% | 31 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $82 → $90 | $89.17 | +0.93% | 45 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $85 | $88.34 | -3.78% | 40 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $66 | $43.72 | +50.96% | 43 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $50.33 | -26.49% | 13 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $2.85 | +5.26% | 30 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $25 | $10.17 | n/a | 8 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $71 → $79 | $74.29 | n/a | 20 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $25 | $18.45 | n/a | 3 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $19 | $15.42 | n/a | 10 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $45.93 | n/a | 1 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $150 → $131 | $94.32 | n/a | 14 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $3.66 → $7 | $13.31 | n/a | 2 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 | $27.69 | n/a | 6 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $18.04 | n/a | 1 | Nov 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $48 → $43 | $20.32 | n/a | 17 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $86 → $70 | $85.49 | n/a | 17 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $20 | $1.99 | n/a | 10 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.03 | n/a | 7 | Feb 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $4.81 | n/a | 11 | Jan 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $7.00 | n/a | 6 | Nov 5, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $22 | - | n/a | 7 | Jul 29, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0005 | n/a | 6 | Feb 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $73 → $63 | $78.17 | n/a | 7 | Jun 5, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $14 | $10.15 | n/a | 4 | Jul 31, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $8.95 | n/a | 1 | Sep 9, 2011 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.59 | n/a | 1 | Jun 28, 2011 |
Stryker
Sep 18, 2026
Reiterated: Buy
Price Target: $300 → $385
Current: $274.19
Upside: +40.41%
TransMedics Group
Sep 11, 2026
Reiterated: Buy
Price Target: $95
Current: $87.29
Upside: +8.83%
iRhythm Holdings
Aug 27, 2026
Reiterated: Buy
Price Target: $196
Current: $110.37
Upside: +77.58%
TriSalus Life Sciences
Aug 26, 2026
Reiterated: Buy
Price Target: $7
Current: $4.98
Upside: +40.56%
Artivion
Aug 18, 2026
Reiterated: Buy
Price Target: $39 → $40
Current: $23.63
Upside: +69.28%
CeriBell
Aug 13, 2026
Reiterated: Buy
Price Target: $25 → $26
Current: $24.25
Upside: +7.22%
AtriCure
Aug 11, 2026
Reiterated: Buy
Price Target: $55
Current: $58.32
Upside: -5.69%
CVRx, Inc.
Aug 11, 2026
Reiterated: Buy
Price Target: $5
Current: $2.97
Upside: +68.35%
Pulse Biosciences
Aug 11, 2026
Reiterated: Buy
Price Target: $32 → $43
Current: $53.31
Upside: -19.34%
Tandem Diabetes Care
Aug 11, 2026
Reiterated: Buy
Price Target: $40
Current: $17.62
Upside: +127.01%
Aug 6, 2026
Reiterated: Buy
Price Target: $249 → $179
Current: $140.53
Upside: +27.37%
Aug 4, 2026
Reiterated: Hold
Price Target: $374
Current: $318.78
Upside: +17.32%
Aug 3, 2026
Reiterated: Buy
Price Target: $82 → $90
Current: $89.17
Upside: +0.93%
Aug 3, 2026
Reiterated: Hold
Price Target: $85
Current: $88.34
Upside: -3.78%
Jul 30, 2026
Reiterated: Buy
Price Target: $70 → $66
Current: $43.72
Upside: +50.96%
Jun 29, 2026
Reiterated: Buy
Price Target: $37
Current: $50.33
Upside: -26.49%
Apr 6, 2026
Reiterated: Buy
Price Target: $3
Current: $2.85
Upside: +5.26%
Jan 22, 2024
Reiterated: Buy
Price Target: $22 → $25
Current: $10.17
Upside: n/a
Jan 22, 2024
Reiterated: Buy
Price Target: $71 → $79
Current: $74.29
Upside: n/a
Jan 22, 2024
Reiterated: Buy
Price Target: $24 → $25
Current: $18.45
Upside: n/a
Dec 21, 2023
Reiterated: Buy
Price Target: $17 → $19
Current: $15.42
Upside: n/a
Dec 21, 2023
Reiterated: Buy
Price Target: $15
Current: $45.93
Upside: n/a
Dec 15, 2023
Reiterated: Hold
Price Target: $150 → $131
Current: $94.32
Upside: n/a
Dec 7, 2023
Upgraded: Buy
Price Target: $3.66 → $7
Current: $13.31
Upside: n/a
Nov 30, 2023
Reiterated: Hold
Price Target: $32
Current: $27.69
Upside: n/a
Nov 7, 2023
Reiterated: Buy
Price Target: $65
Current: $18.04
Upside: n/a
Sep 15, 2023
Reiterated: Hold
Price Target: $48 → $43
Current: $20.32
Upside: n/a
Aug 28, 2023
Reiterated: Hold
Price Target: $86 → $70
Current: $85.49
Upside: n/a
Feb 23, 2023
Reiterated: Buy
Price Target: $16 → $20
Current: $1.99
Upside: n/a
Feb 2, 2016
Reiterated: Buy
Price Target: $8
Current: $1.03
Upside: n/a
Jan 11, 2016
Reiterated: Buy
Price Target: $12
Current: $4.81
Upside: n/a
Nov 5, 2015
Reiterated: Buy
Price Target: $16
Current: $7.00
Upside: n/a
Jul 29, 2015
Reiterated: Hold
Price Target: $25 → $22
Current: -
Upside: n/a
Feb 2, 2015
Reiterated: Hold
Price Target: n/a
Current: $0.0005
Upside: n/a
Jun 5, 2014
Reiterated: Buy
Price Target: $73 → $63
Current: $78.17
Upside: n/a
Jul 31, 2013
Reiterated: Hold
Price Target: $17 → $14
Current: $10.15
Upside: n/a
Sep 9, 2011
Reiterated: Buy
Price Target: $45
Current: $8.95
Upside: n/a
Jun 28, 2011
Reiterated: Buy
Price Target: n/a
Current: $15.59
Upside: n/a